GlassScriptPhysician profile
Alyssa Seldes
NPI 1235793852
$2,473.45
in general payments reported to CMS, 2019-2025
20 companies · $248 in 2025
The $248 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,237 · 2022: $839 · 2023: $84.65 · 2024: $65.00 · 2025: $248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $397.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $633.25 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $478.65 | 2021 | |
| Lilly USA, LLC | $214.97 | 2021-2025 | Kisunla |
| Biohaven Pharmaceutical Holding Company LTD. | $159.29 | 2022 | |
| Ucb, INC. | $145.29 | 2021-2022 | |
| Biogen, INC. | $136.12 | 2021-2022 | |
| Microtransponder, INC. | $125.81 | 2025 | |
| Novo Nordisk INC | $110.99 | 2022 | |
| Immedica Pharma US, INC. | $84.65 | 2023 | |
| Sk Life Science, INC. | $66.79 | 2021-2022 | |
| Chiesi USA, INC. | $65.00 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $53.83 | 2021-2022 | |
| Eisai INC. | $44.76 | 2021-2022 | |
| Upsher-Smith Laboratories LLC | $28.11 | 2021 | |
| Impel Pharmaceuticals INC. | $24.62 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $24.07 | 2021 | |
| Novartis Pharmaceuticals Corporation | $23.52 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $19.78 | 2021 | |
| Neurelis, INC. | $19.75 | 2021 | |
| Allergan, INC. | $14.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alyssa Seldes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.